Inqo Investments Limited (AQU:INQO)
London · Delayed Price · Currency is GBP · Price in GBX 48.50
0.00 (0.00%)
At close: Nov 12, 2025
Inqo Investments Revenue
In the fiscal year ending February 28, 2025, Inqo Investments had annual revenue of 25.86M ZAR with 25.49% growth. Inqo Investments had revenue of 17.67M in the half year ending February 28, 2025, with 111.79% growth.
Revenue
25.86M ZAR
Revenue Growth
+25.49%
P/S Ratio
7.18
Revenue / Employee
562.28K ZAR
Employees
46
Market Cap
7.94M GBP
Revenue Chart
* This company reports financials in ZAR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 25.86M | 5.25M | 25.49% |
| Feb 29, 2024 | 20.61M | 8.88M | 75.71% |
| Feb 28, 2023 | 11.73M | 7.86M | 202.95% |
| Feb 28, 2022 | 3.87M | -342.58K | -8.13% |
| Feb 28, 2021 | 4.21M | -20.21M | -82.74% |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |